IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo.
Saved in:
| Title: | IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo. |
|---|---|
| Authors: | Lin CC; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine National Taiwan University Taipei Taiwan., Yao CY; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan., Wang YH; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan., Hsu YC; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan., Yuan CT; Graduate Institute of Clinical Medicine, College of Medicine National Taiwan University Taipei Taiwan.; Department of Pathology Graduate Institute of Oncology College of Medicine National Taiwan University Taipei Taiwan.; Department of Pathology National Taiwan University Cancer Center Taipei Taiwan., Chen TC; Graduate Institute of Clinical Medicine, College of Medicine National Taiwan University Taipei Taiwan.; Division of Hematology and Medical Oncology Department of Internal Medicine Taichung Veterans General Hospital Taipei Taiwan., Hsu CL; Department of Medical Research National Taiwan University Cancer Center Taipei Taiwan., Lee SH; Division of Cellular Therapy Department of Integrated Diagnostics and Therapeutics National Taiwan University Hospital Taipei Taiwan., Lee JY; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan., Shih PT; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan., Kao CJ; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan., Chuang PH; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan., Kuo YY; Tai-Cheng Stem Cell Therapy Center National Taiwan University Taipei Taiwan., Hou HA; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan., Chou WC; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan., Tien HF; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.; Division of Hematology and Medical Oncology Department of Internal Medicine Far Eastern Memorial Hospital New Taipei Taiwan. |
| Source: | EJHaem [EJHaem] 2024 Jul 28; Vol. 5 (4), pp. 738-748. Date of Electronic Publication: 2024 Jul 28 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
